Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Shenyang Xingqi Pharmaceutical Co.,Ltd.

Capitalization 1.32TCr 194.91Cr 168.79Cr 154.87Cr 145.71Cr 271.39Cr 19TCr 275.64Cr 1.84TCr 716.44Cr 8.98TCr 731.83Cr 715.91Cr 31TCr P/E ratio 2024
36.2x
P/E ratio 2025 24.8x
Enterprise value 1.29TCr 190.3Cr 164.8Cr 151.22Cr 142.27Cr 264.98Cr 18TCr 269.13Cr 1.8TCr 699.53Cr 8.77TCr 714.55Cr 699.01Cr 30TCr EV / Sales 2024
6.21x
EV / Sales 2025 6.88x
Free-Float
67.44%
Yield 2024
2.15%
Yield 2025 2.42%
1 day+0.71%
1 week-3.88%
Current month-3.88%
1 month-22.77%
3 months-24.62%
6 months-26.58%
Current year-23.78%
1 week 36.5
Extreme 36.5
38.94
1 month 36.5
Extreme 36.5
49.38
Current year 36.5
Extreme 36.5
58.92
1 year 34.37
Extreme 34.3655
59.07
3 years 31.96
Extreme 31.9606
105.6
5 years 19.73
Extreme 19.7296
105.6
10 years 1.56
Extreme 1.5557
105.6
Manager TitleAgeSince
Chief Executive Officer 52 18/07/2022
Director of Finance/CFO 52 12/11/2011
Chief Administrative Officer 49 16/02/2022
Director TitleAgeSince
Chairman 69 05/07/2000
Director/Board Member 52 12/11/2011
Director/Board Member 56 15/01/2015
Date Insider Type Main position Quantity % Market Cap.
24/20/24Sell

Chief Financial Officer

5,000 0.0083%
23/20/23Sell

Chief Financial Officer

5,000 0.0083%
15/20/15Sell

Chief Executive Officer

50,000 0.0826%
Change 5d. change 1-year change 3-years change Capi.($)
+0.71%-3.88%-1.20%-18.81% 194.91Cr
-0.44%+4.24%+17.69%-19.39% 6.87TCr
-0.10%+7.50%+31.85%+106.02% 848.44Cr
+3.21%-2.98%-3.92%-12.56% 747.68Cr
-2.65%-1.78%-2.54%+18.26% 443.49Cr
-3.25%-8.82%-25.34%+34.06% 371.67Cr
+1.66%-7.21%-21.79%-3.49% 303.59Cr
+0.11%-3.10%+34.99%+26.23% 259.73Cr
+1.01%-3.45%-16.65%-23.02% 177.39Cr
-0.82%-5.89%+11.57%+17.63% 167.06Cr
Average -0.06%-2.90%+2.47%+12.49% 1.04TCr
Weighted average by Cap. -0.25%+2.18%+13.12%-2.98%

Financials

2024 2025
Net sales 194.34Cr 29Cr 25Cr 23Cr 21Cr 40Cr 2.73TCr 41Cr 270.96Cr 105.45Cr 1.32TCr 107.72Cr 105.38Cr 4.6TCr 247.29Cr 37Cr 32Cr 29Cr 27Cr 51Cr 3.48TCr 52Cr 344.78Cr 134.19Cr 1.68TCr 137.07Cr 134.08Cr 5.85TCr
Net income 34Cr 4.99Cr 4.32Cr 3.97Cr 3.73Cr 6.95Cr 475.56Cr 7.06Cr 47Cr 18Cr 229.99Cr 19Cr 18Cr 799.79Cr 70Cr 10Cr 8.9Cr 8.16Cr 7.68Cr 14Cr 978.88Cr 15Cr 97Cr 38Cr 473.4Cr 39Cr 38Cr 1.65TCr
Net Debt -15Cr -2.29Cr -1.98Cr -1.82Cr -1.71Cr -3.18Cr -217.78Cr -3.23Cr -22Cr -8.4Cr -105.32Cr -8.58Cr -8.39Cr -366.26Cr -31Cr -4.6Cr -3.98Cr -3.66Cr -3.44Cr -6.41Cr -438.46Cr -6.51Cr -43Cr -17Cr -212.04Cr -17Cr -17Cr -737.39Cr
Logo Shenyang Xingqi Pharmaceutical Co.,Ltd.
Shenyang Xingqi Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of ophthalmic drugs. The Company's main products include drugs for delaying the progression of myopia in children, drugs for the treatment of dry eyes, ophthalmic anti-infective drugs, ophthalmic anti-inflammatory/anti-infective drugs, pupil dilatant and ciliary muscle paralyzer drugs, ophthalmic non-steroidal anti-inflammatory drugs, miotic drugs, anti-glaucoma drugs and others. The Company is also engaged in health food production, inspection and testing services, drug import and export, plastic product manufacturing, non-residential real estate leasing, machinery and equipment leasing and other businesses. The Company mainly operates its businesses in the domestic market.
Employees
2,396
Date Price Change Volume
05/26/05 36.95 ¥ +0.71% 68,09,610
04/26/04 36.69 ¥ -2.96% 73,97,371
03/26/03 37.81 ¥ -2.32% 65,19,850
02/26/02 38.71 ¥ -0.26% 53,33,934
01/26/01 38.81 ¥ +0.96% 74,25,733

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300573 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
BENEFIT NOW